Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy)

This publication has 17 references indexed in Scilit:

• Three are discrepancies between the results of antimicrobial susceptibility testing of Helicobacter pylori using E-test compared to broth microdilution or disk diffusion: C.Y. Hachem, J.E. Clarridge, R. Reddy, R. Flamm, D.G. Evans, D.Y. Graham. VAMC and Baylor College of Medicine, Houston, TX and Abbott Labs, Abbott Park, IL
  Gastroenterology, 1995
• Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection
  Alimentary Pharmacology & Therapeutics, 1995
• Benefits from Elimination of Helicobacter pylori Infection Include Major Reduction in the Incidence of Peptic Ulcer Disease, Gastric Cancer, and Primary Gastric Lymphoma
  Preventive Medicine, 1994
• NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease
  JAMA, 1994
• Helicobacter pylori
  Archives of internal medicine (1960), 1994
• Treatment Strategies for Symptom Resolution, Healing, andHelicobacter pyloriEradication in Duodenal Ulcer Patients
  Scandinavian Journal of Gastroenterology, 1994
• Helicobacter pylori
  Published by Springer Nature ,1991
• Helicobacter pylori and metronidazole resistance
  The Lancet, 1990
• Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
  Gut, 1990
• Metronidazole resistance in Helicobacter pylori
  The Lancet, 1990